Last year was a tough one for farmers. Amid falling prices for commodity crops such as corn and soybeans, rising input costs for supplies like fertilizer and seeds, as well as the Trump tariffs and the dismantling of USAID, many farms weren’t profitable last year. And now, the enhanced Affordable Care Act subsidies that many…
How will HEOR leaders respond to recent policy changes? A survey from Tufts and the Center for the Evaluation of Value and Risk in Health (CEVR) provides the answer. About 2/3 of the n=57 respondents were Head of their HEOR department and the remaining 1/3 had some other senior level HEOR role. Three key topic…
NIH-backed startup Amissa has launched an AI-powered platform that aggregates data from multiple sources to improve how menopause and perimenopause are tracked and treated. The post NIH-Backed Startup Amissa Unveils AI Platform to Improve Menopause Care appeared first on MedCity News.
This week, Congress reached a bipartisan healthcare deal as part of a larger $1.2 trillion spending bill, combining funding increases, policy reforms and program extensions. The proposal maintains key programs like CMS coverage for telehealth and hospital-at-home care, but stops short of renewing enhanced ACA premium tax credits. The post Congress’ New Healthcare Package: 7…
Jensen Huang, CEO of Nvidia and David Ricks, CEO of Eli Lilly, discussed their recently-announced partnership and the potential of GLP-1s at an event in San Francisco. The post Nvidia CEO to Lilly CEO: You were running around the forest … appeared first on MedCity News.
After a year of ongoing measles outbreaks that have sickened more than 2,400 people, the United States is poised to lose its status as a measles-free country. However, the newly appointed principal deputy director at the Centers for Disease Control and Prevention, Ralph Abraham, said he was unbothered by the prospect at a briefing for…
Pfizer’s stake in ViiV Healthcare will be taken over by Shiongi, another minority shareholder in the HIV medicines company. GSK remains remain the majority shareholder in ViiV, which the pharmaceutical giant formed in partnership with Pfizer in 2009. The post Pfizer Pockets $1.9B by Offloading Stake in HIV Drugs Company Majority-Owned by GSK appeared first…
[Sponsored] Mobile IV therapy has become an increasingly popular wellness solution in Austin, offering fast hydration, nutrient delivery and recovery support without the need to visit a clinic. The post Top-Rated Mobile IV Therapy Companies in Austin, Texas: Price and Quality Compared appeared first on MedCity News.
[Sponsored] A webinar on Thursday, January 22 at 1 pm ET will discuss the findings of a report sponsored by Smarter Technologies on what medical practices need from and the benefits of AI for revenue cycle management. The post The Quest to Transform Bill Collection for Medical Practices appeared first on MedCity News.
AI’s contribution to medical-device development isn’t about replacing engineers, regulatory specialists, or clinical teams. It’s about clearing the friction points that steal time and force expensive rework and optimize time-to-market. The post How AI Is Actually Helping MedTech Teams Move Faster — Across Every Stage of Medical Device Development appeared first on MedCity News.